Heat shock protein family A member 8 is a prognostic marker for bladder cancer: Evidences based on experiments and machine learning

被引:4
|
作者
Liu, Yang [1 ]
Pang, Zhong-qi [1 ]
Wang, Jian-she [1 ]
Wang, Jin-feng [1 ]
He, Jia-xin [1 ]
Ji, Bo [1 ]
Zhang, Lu [1 ]
Ren, Ming-hua [1 ,2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Urinary Surg, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Dept Urinary Surg, Affiliated Hosp 1, Harbin 150007, Peoples R China
关键词
bladder cancer; HSPA8; immune infiltration; prognostic maker; risk model; ADHESION; HSC70; P53;
D O I
10.1111/jcmm.17977
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heat shock protein member 8 (HSPA8) is one of the most abundant chaperones in eukaryotic cells, but its biological roles in bladder cancer (BC) are largely unclear. First, we observed that HSPA8 was abundant in both cell lines and tissues of BC, and the HSPA8-high group had poorer T stages and overall survival (OS) than the HSPA8-low group in the TCGA patients. Next, when we knocked down HSPA8 in BC cells, the growth and migration abilities were significantly decreased, the apoptosis rates were significantly increased, and the Ki67 fluorescence intensity was decreased in BC cells. Moreover, caspase 3 was significantly decreased with overexpression of HSPA8 in BC cells. After that, a machine learning prognostic model was created based on the expression of HSPA8 by applying LASSO Cox regression in TCGA and GEO patients. The model indicated that the low-risk (LR) group with BC had better tumour stages, lymphovascular invasion, and OS than the high-risk (HR) group. Additionally, the risk score was demonstrated to be an independent risk factor for the prognosis of BC by univariate and multivariate Cox analyses. Moreover, the HR group showed a greater rate of TP53 mutations and was mostly enriched in the ECM-receptor interaction pathway than the LR group. Importantly, lower CD8+ T-cell and NK cell infiltration, higher immune exclusion scores, higher expression of PD-L1 and CTLA4 and poorer immune checkpoint therapy effects were found in the HR group. These findings demonstrated how crucial HSPA8 plays a role in determining the prognosis of bladder cancer.
引用
收藏
页码:3995 / 4008
页数:14
相关论文
共 5 条
  • [1] A human pan-cancer system analysis of heat shock protein family A member 5
    Deng, Chao
    Gong, Siming
    Lin, Lizhen
    Tang, Juyu
    Pang, Xiaoyang
    Wu, Panfeng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (05): : 1698 - +
  • [2] Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer
    Wang, Zhen
    Chen, Dong-Ning
    Huang, Xu-Yun
    Zhu, Jun-Ming
    Lin, Fei
    You, Qi
    Lin, Yun-Zhi
    Cai, Hai
    Wei, Yong
    Xue, Xue-Yi
    Zheng, Qing-Shui
    Xu, Ning
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138
  • [3] A machine learning-based prognostic signature utilizing MSC proteomics for predicting bladder cancer prognosis and treatment response
    Zhang, Xinyu
    Li, Pan
    Ji, Luhua
    Zhang, Yuanfeng
    Zhang, Ze
    Guo, Yufeng
    Zhang, Luyang
    Jing, Suoshi
    Dong, Zhilong
    Tian, Junqiang
    Yang, Li
    Ding, Hui
    Yang, Enguang
    Wang, Zhiping
    TRANSLATIONAL ONCOLOGY, 2025, 54
  • [4] Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression
    Gianniou, Despoina D.
    Sklirou, Aimilia D.
    Papadimitriou, Maria-Alexandra
    Pilala, Katerina-Marina
    Stravodimos, Konstantinos
    Avgeris, Margaritis
    Scorilas, Andreas
    Trougakos, Ioannis P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [5] Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study
    Li, Jingxian
    Kong, Zheng
    Qi, Yuanjiong
    Wang, Wei
    Su, Qiang
    Huang, Wei
    Zhang, Zhihong
    Li, Shuai
    Du, E.
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (08) : 4911 - 4931